Neuroscience
From the FDA:
FDA Approves Saphris to Treat Schizophrenia and Bipolar Disorder
The U.S. Food and Drug Administration has approved Saphris tablets (asenapine) to treat adults with schizophrenia, a chronic, severe and disabling brain disorder, and to treat bipolar I disorder in adults, a serious psychiatric disorder that causes shifts in a person's mood, energy, and ability to function.
“Mental illnesses like schizophrenia and bipolar disorder can be devastating to patients and families, requiring lifelong treatment and therapy,” said Thomas Laughren, M.D., director of the Division of Psychiatry Products in the FDA’s Center for Drug Evaluation and Research. “Effective medicines can help people with mental illness live more independent lives.”
Read the full FDA press release
S-P corporate press release
- No Schizophrenia?
2 NAMES, 1 DISEASE: Does schizophrenia=psychotic bipolar disorder? in Current Psychiatry suggests that schizophrenia is actually severe bipolar I psychosis and not a separate diagnosis. A comprehensive review references questions going back many years,...
- News From The Fda: Onfi Tablets (clobazam) For Adjunctive Treatment In Lennox-gastaut Syndrome
From the FDA: FDA NEWS RELEASE For Immediate Release: Oct. 24, 2011 FDA approves Onfi to treat severe type of seizures On Oct. 21, the U.S. Food and Drug Administration approved Onfi tablets (clobazam) for use as an adjunctive (add-on) treatment for...
- Fda: Lundbeck's Sabril (vigabatrin) And Infantile Spasms
From a press release by the FDA: Sabril Approved by FDA to Treat Spasms in Infants and Epileptic Seizures Sabril (vigabatrin) Oral Solution has been approved by the U.S. Food and Drug Administration to treat infantile spasms in children ages 1 month to...
- Fda Approves Invega (paliperidone)
An FDA Press Release: FOR IMMEDIATE RELEASE P06-208 December 20, 2006 Media Inquiries: Press Office, 301-827-6242 Consumer Inquiries: 888-INFO-FDA FDA Approves New Drug for Schizophrenia The Food and Drug Administration (FDA) today approved Invega (paliperidone)...
- Fda: Alzheimer Disease, Aricept (donepezil Hydrochloride)
From the FDA last week: FDA Approves Expanded Use of Treatment for Patients With Severe Alzheimer's Disease FOR IMMEDIATE RELEASE P06-168 October 13, 2006 Media Inquiries: Susan Cruzan, 301-827-6242 Consumer Inquiries: 888-INFO-FDA...
Neuroscience
FDA: Saphris (Asenapine) Approval, Schizophrenia and Bipolar
From the FDA:
FDA Approves Saphris to Treat Schizophrenia and Bipolar Disorder
The U.S. Food and Drug Administration has approved Saphris tablets (asenapine) to treat adults with schizophrenia, a chronic, severe and disabling brain disorder, and to treat bipolar I disorder in adults, a serious psychiatric disorder that causes shifts in a person's mood, energy, and ability to function.
“Mental illnesses like schizophrenia and bipolar disorder can be devastating to patients and families, requiring lifelong treatment and therapy,” said Thomas Laughren, M.D., director of the Division of Psychiatry Products in the FDA’s Center for Drug Evaluation and Research. “Effective medicines can help people with mental illness live more independent lives.”
Read the full FDA press release
S-P corporate press release
- No Schizophrenia?
2 NAMES, 1 DISEASE: Does schizophrenia=psychotic bipolar disorder? in Current Psychiatry suggests that schizophrenia is actually severe bipolar I psychosis and not a separate diagnosis. A comprehensive review references questions going back many years,...
- News From The Fda: Onfi Tablets (clobazam) For Adjunctive Treatment In Lennox-gastaut Syndrome
From the FDA: FDA NEWS RELEASE For Immediate Release: Oct. 24, 2011 FDA approves Onfi to treat severe type of seizures On Oct. 21, the U.S. Food and Drug Administration approved Onfi tablets (clobazam) for use as an adjunctive (add-on) treatment for...
- Fda: Lundbeck's Sabril (vigabatrin) And Infantile Spasms
From a press release by the FDA: Sabril Approved by FDA to Treat Spasms in Infants and Epileptic Seizures Sabril (vigabatrin) Oral Solution has been approved by the U.S. Food and Drug Administration to treat infantile spasms in children ages 1 month to...
- Fda Approves Invega (paliperidone)
An FDA Press Release: FOR IMMEDIATE RELEASE P06-208 December 20, 2006 Media Inquiries: Press Office, 301-827-6242 Consumer Inquiries: 888-INFO-FDA FDA Approves New Drug for Schizophrenia The Food and Drug Administration (FDA) today approved Invega (paliperidone)...
- Fda: Alzheimer Disease, Aricept (donepezil Hydrochloride)
From the FDA last week: FDA Approves Expanded Use of Treatment for Patients With Severe Alzheimer's Disease FOR IMMEDIATE RELEASE P06-168 October 13, 2006 Media Inquiries: Susan Cruzan, 301-827-6242 Consumer Inquiries: 888-INFO-FDA...